(NYSE: RMD) Resmed's forecast annual earnings growth rate of 11.02% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 15.54%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.75%.
Resmed's earnings in 2025 is $1,313,254,000.On average, 8 Wall Street analysts forecast RMD's earnings for 2026 to be $1,528,766,587, with the lowest RMD earnings forecast at $1,441,347,332, and the highest RMD earnings forecast at $1,634,895,499. On average, 6 Wall Street analysts forecast RMD's earnings for 2027 to be $1,664,470,245, with the lowest RMD earnings forecast at $1,570,379,443, and the highest RMD earnings forecast at $1,813,780,926.
In 2028, RMD is forecast to generate $1,785,921,720 in earnings, with the lowest earnings forecast at $1,785,921,720 and the highest earnings forecast at $1,785,921,720.